Overview
Timothy Coblentz is an Urologist in Canton, Ohio. Dr. Coblentz is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Malakoplakia, Enlarged Prostate (BPH), Familial Prostate Cancer, Ureteroscopy, and Nephrectomy. Dr. Coblentz is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- HMO
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2600 Tuscarawas St W, Suite 600, Canton, OH 44708
2600 6th St Sw, Canton, OH 44710
Cleveland Clinic Main Campus
Christopher Weight is an Urologist in Cleveland, Ohio. Dr. Weight is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.
Cleveland Clinic Main Campus
Byron Lee is an Urologist in Cleveland, Ohio. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.
University Hospitals Medical Group Inc
Adam Calaway is an Urologist in Cleveland, Ohio. Dr. Calaway is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Testicular Cancer, Teratoma of the Mediastinum, Nephrectomy, and Cystectomy. Dr. Calaway is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Enlarged Prostate (BPH)Dr. Coblentz isDistinguished. Learn about Enlarged Prostate (BPH).
- Familial Prostate CancerDr. Coblentz isDistinguished. Learn about Familial Prostate Cancer.
- MalakoplakiaDr. Coblentz isDistinguished. Learn about Malakoplakia.
- Obstructive UropathyDr. Coblentz isDistinguished. Learn about Obstructive Uropathy.
- Prostate CancerDr. Coblentz isDistinguished. Learn about Prostate Cancer.
- UPJ ObstructionDr. Coblentz isDistinguished. Learn about UPJ Obstruction.
- Advanced
- BalanitisDr. Coblentz isAdvanced. Learn about Balanitis.
- Bilateral HydronephrosisDr. Coblentz isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Coblentz isAdvanced. Learn about Bladder Cancer.
- Bladder Outlet ObstructionDr. Coblentz isAdvanced. Learn about Bladder Outlet Obstruction.
- Bladder StonesDr. Coblentz isAdvanced. Learn about Bladder Stones.
- BoilsDr. Coblentz isAdvanced. Learn about Boils.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Coblentz isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Asymptomatic BacteriuriaDr. Coblentz isExperienced. Learn about Asymptomatic Bacteriuria.
- Autosomal Dominant Tubulointerstitial Kidney Disease
- Bacterial ProstatitisDr. Coblentz isExperienced. Learn about Bacterial Prostatitis.
- Chromophobe Renal Cell CarcinomaDr. Coblentz isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Coblentz isExperienced. Learn about Clear Cell Sarcoma.